Prevalence of Retinal Venous Malformations in Patients With Cerebral Cavernous or Arteriovenous Malformations

Authors:
Publisher website
Google Scholar
Abstract
Background: Cerebral vascular malformations (CVMs) may result in hemorrhage, seizure, neurologic dysfunction, and death. CVMs include capillary telangiectasias, venous malformations, cavernous malformations, and arteriovenous malformations. Cavernous and arteriovenous malformations carry the highest risk of complications. Retinal venous malformations (RVMs) have been proposed as an associated finding. Our objective was to determine the prevalence of RVMs in patients with high-risk CVMs. Methods: We retrospectively reviewed patients diagnosed with cerebral cavernous or arteriovenous malformations (high-risk CVMs) who were evaluated by the ophthalmology service at Northwestern University between 2017 and 2020. Patients were stratified into 3 cohorts based on level of certainty: dilated funduscopic examination (DFE), DFE with any form of ocular imaging, and DFE with complete imaging of the macula. We recorded ophthalmic examination abnormalities, ocular imaging findings, and major CVM complications. Results: We evaluated 156 patients with high-risk CVMs who had undergone DFE. Ocular imaging of any type was performed in 56 patients, of whom 46 had complete imaging of the macula. Zero RVMs were identified in any cohort (95% confidence interval: 0%–1.9% for the entire cohort, 0%–5.4% for any ocular imaging cohort, and 0%–6.5% for the complete macular imaging cohort). Cerebral hemorrhage or seizure occurred in 15%–33% of patients. Associated visual field defects or cranial nerve palsies were found in 14%–20% of patients. Conclusions: Zero RVMs were identified in patients with high-risk CVMs. However, neuro-ophthalmic findings were common. Therefore, we recommend neuroimaging for patients with RVMs and neuro-ophthalmic signs or symptoms. In asymptomatic patients with RVMs, a potential algorithm for neuroimaging is proposed.
Funding Information
  • Illinois Society for the Prevention of Blindness
  • Research to Prevent Blindness (Medical Student Eye Research Fellowship)
  • Research to Prevent Blindness (Sybil B. Harrington Career Development Award for Macular Degeneration)
  • National Institutes of Health (K08 EY030923)
  • Research to Prevent Blindness (Unrestricted Departmental Grant)

This publication has 18 references indexed in Scilit: